Is a complete TEVA research report available?

No complete published report is available for Teva Pharmaceutical Industries Limited (TEVA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Teva Pharmaceutical Industries Limited (TEVA)

NYSE: TEVA · USD

$39.9

-0.50 (-1.2%)· Recorded snapshot

Market cap	46.5B
Revenue (ttm)	17.3B
Net income (ttm)	706M
EPS (ttm)	$0.60
Shares out	1.2B
P/E (trailing)	66.3x
P/E (forward)	14.2x
Volume	3,355,055
Beta	0.82

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Metric	Value
Amount currency	USD
CIK code	0000818686
Company name	Teva Pharmaceutical Industries Limited
Country	Israel
Country code	US
Earnings date	2026-11-03
Earnings time	bmo
Employees	33,950
Employees change	-2,880
Employees growth	-7.82%
Enterprise value	$59.7B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1901
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
Is SPAC	No
ISIN number	IL0006290147
Last 10-K release date	2026-02-03
Last earnings date	2026-07-29
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$46.5B
Market cap category	Large-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$39.90
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	TEVA
Website	https://www.tevapharm.com

Metric

Value

Amount currency

USD

CIK code

0000818686

Company name

Teva Pharmaceutical Industries Limited

Country

Israel

Country code

Earnings date

2026-11-03

Earnings time

bmo

Employees

33,950

Employees change

-2,880

Employees growth

-7.82%

Enterprise value

$59.7B

Exchange

NYSE

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1901

Industry

Drug Manufacturers - Specialty & Generic

Is primary listing

Yes

Is SPAC

ISIN number

IL0006290147

Last 10-K release date

2026-02-03

Last earnings date

2026-07-29

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$46.5B

Market cap category

Large-Cap

Next earnings date

2026-11-03

Options

Yes

Price

$39.90

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

TEVA

Website

https://www.tevapharm.com

Metric	Value
Earnings yield	1.51%
EV/Earnings	84.81x
EV/EBIT	18.25x
EV/EBITDA	14.03x
EV/FCF	44.45x
EV/Sales	3.46x
FCF / EV yield	2.25%
FCF yield	2.89%
Forward EV/Sales	3.57x
Forward P/E	14.16x
Forward P/S	2.78x
Graham number	9.49057
Graham upside	-76.29%
Industry forward P/E	13.87x
Industry P/E	173.94x
P/(FCF - SBC) ratio	39.55x
P/(OCF - SBC) ratio	26.96x
P/B ratio	6.07x
P/E ratio	66.31x
P/FCF ratio	34.62x
P/OCF ratio	24.57x
P/S ratio	2.69x
PEG ratio	1.96x
Price/EBITDA ratio	10.93x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

1.51%

EV/Earnings

84.81x

EV/EBIT

18.25x

EV/EBITDA

14.03x

EV/FCF

44.45x

EV/Sales

3.46x

FCF / EV yield

2.25%

FCF yield

2.89%

Forward EV/Sales

3.57x

Forward P/E

14.16x

Forward P/S

2.78x

Graham number

9.49057

Graham upside

-76.29%

Industry forward P/E

13.87x

Industry P/E

173.94x

P/(FCF - SBC) ratio

39.55x

P/(OCF - SBC) ratio

26.96x

P/B ratio

6.07x

P/E ratio

66.31x

P/FCF ratio

34.62x

P/OCF ratio

24.57x

P/S ratio

2.69x

PEG ratio

1.96x

Price/EBITDA ratio

10.93x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	18.94%
EBITDA margin	24.65%
Effective tax rate	1.67%
FCF margin	7.78%
Gross margin	52.46%
Operating margin	18.94%
Pretax margin	4.15%
Profit margin	4.08%
Profit per employee	$20,795
Profitable years	1
Revenue per employee	$510,015
ROA	5.13%
ROA (5Y)	4.67%
ROCE	13.55%
ROE	9.69%
ROE (5Y)	-7.19%
ROIC	15.21%
ROIC (5Y)	12.12%
SBC / revenue	0.97%
Tax / revenue	0.07%

Metric

Value

EBIT margin

18.94%

EBITDA margin

24.65%

Effective tax rate

1.67%

FCF margin

7.78%

Gross margin

52.46%

Operating margin

18.94%

Pretax margin

4.15%

Profit margin

4.08%

Profit per employee

$20,795

Profitable years

Revenue per employee

$510,015

ROA

5.13%

ROA (5Y)

4.67%

ROCE

13.55%

ROE

9.69%

ROE (5Y)

-7.19%

ROIC

15.21%

ROIC (5Y)

12.12%

SBC / revenue

0.97%

Tax / revenue

0.07%

Metric	Value
EPS growth 10Y	-8.71%
EPS growth years	1
FCF growth	51.35%
FCF growth (Q)	134.35%
FCF growth 3Y	4.72%
Gross profit growth	10.14%
Gross profit growth (Q)	2.43%
Gross profit growth 3Y	10.04%
Gross profit growth 5Y	3.49%
Net income growth years	1
OCF growth	36.55%
OCF growth (Q)	81.06%
OCF growth 10Y	-9.32%
OCF growth 3Y	3.84%
OCF growth 5Y	33.3%
Operating income growth	-6.31%
Operating income growth (Q)	-81.32%
Operating income growth 3Y	9.75%
Operating income growth 5Y	2.42%
Revenue growth	4.13%
Revenue growth (Q)	-0.81%
Revenue growth (QoQ)	4.02%
Revenue growth 10Y	-1.21%
Revenue growth 3Y	4.86%
Revenue growth 5Y	1.19%
Revenue growth years	3

Metric

Value

EPS growth 10Y

-8.71%

EPS growth years

FCF growth

51.35%

FCF growth (Q)

134.35%

FCF growth 3Y

4.72%

Gross profit growth

10.14%

Gross profit growth (Q)

2.43%

Gross profit growth 3Y

10.04%

Gross profit growth 5Y

3.49%

Net income growth years

OCF growth

36.55%

OCF growth (Q)

81.06%

OCF growth 10Y

-9.32%

OCF growth 3Y

3.84%

OCF growth 5Y

33.3%

Operating income growth

-6.31%

Operating income growth (Q)

-81.32%

Operating income growth 3Y

9.75%

Operating income growth 5Y

2.42%

Revenue growth

4.13%

Revenue growth (Q)

-0.81%

Revenue growth (QoQ)

4.02%

Revenue growth 10Y

-1.21%

Revenue growth 3Y

4.86%

Revenue growth 5Y

1.19%

Revenue growth years

Metric	Value
Capital expenditures	$-551M
Depreciation and amortization	$988M
EBIT	$3.3B
EBITDA	$4.3B
EPS	$0.60
FCF per share	$1.16
Financing cash flow	$-401M
Free cash flow	$1.3B
Free cash flow minus SBC	$1.2B
Gross profit	$9.1B
Income taxes	$12M
Investing cash flow	$37M
Net borrowing	$-474M
Net cash flow	$1.5B
Net income	$706M
Operating cash flow minus SBC	$1.7B
Operating income	$3.3B
Revenue	$17.3B
Stock-based compensation	$168M

Metric

Value

Capital expenditures

$-551M

Depreciation and amortization

$988M

EBIT

$3.3B

EBITDA

$4.3B

EPS

$0.60

FCF per share

$1.16

Financing cash flow

$-401M

Free cash flow

$1.3B

Free cash flow minus SBC

$1.2B

Gross profit

$9.1B

Income taxes

$12M

Investing cash flow

$37M

Net borrowing

$-474M

Net cash flow

$1.5B

Net income

$706M

Operating cash flow minus SBC

$1.7B

Operating income

$3.3B

Revenue

$17.3B

Stock-based compensation

$168M

Metric	Value
Altman Z-Score	0.68
Book value per share	$6.65
Debt / EBITDA	3.84
Debt / equity	2.18
Debt / FCF	12.54
Goodwill	$15.8B
Interest coverage	3.81
Long-term assets	$26.1B
Long-term liabilities	$16.5B
Net cash (debt)	$-13.2B
Net cash / market cap	-28.39%
Net debt / EBITDA	3.1
Net debt / equity	1.71
Net debt / FCF	9.83
Piotroski F-Score	7
Property, plant and equipment	$4.3B
Shareholders' equity	$7.8B
Tangible book value	$-11.5B
Tangible book value per share	$-9.90
Total assets	$39.9B
Total cash	$3.7B
Total debt	$16.9B
Total liabilities	$32.1B
WACC	7.75%

Metric

Value

Altman Z-Score

0.68

Book value per share

$6.65

Debt / EBITDA

3.84

Debt / equity

2.18

Debt / FCF

12.54

Goodwill

$15.8B

Interest coverage

3.81

Long-term assets

$26.1B

Long-term liabilities

$16.5B

Net cash (debt)

$-13.2B

Net cash / market cap

-28.39%

Net debt / EBITDA

3.1

Net debt / equity

1.71

Net debt / FCF

9.83

Piotroski F-Score

Property, plant and equipment

$4.3B

Shareholders' equity

$7.8B

Tangible book value

$-11.5B

Tangible book value per share

$-9.90

Total assets

$39.9B

Total cash

$3.7B

Total debt

$16.9B

Total liabilities

$32.1B

WACC

7.75%

Metric	Value
Asset turnover	0.43
Current assets	$13.8B
Current liabilities	$15.6B
Current ratio	0.88
Inventory turnover	2.45
Net working capital	$-1B
Quick ratio	0.46
Working capital	$-1.9B
Working capital turnover	-30.73

Metric

Value

Asset turnover

0.43

Current assets

$13.8B

Current liabilities

$15.6B

Current ratio

0.88

Inventory turnover

2.45

Net working capital

$-1B

Quick ratio

0.46

Working capital

$-1.9B

Working capital turnover

-30.73

Metric	Value
Buyback yield / dilution	-2.24%
Dividend growth (10Y)	8.28%
Dividend growth (3Y)	-14.39%
Dividend growth (5Y)	-2.11%
Dividend per share	$0.00
Dividend yield	0%
Last dividend	$0.07
Shareholder yield	-2.24%

Metric

Value

Buyback yield / dilution

-2.24%

Dividend growth (10Y)

8.28%

Dividend growth (3Y)

-14.39%

Dividend growth (5Y)

-2.11%

Dividend per share

$0.00

Dividend yield

Last dividend

$0.07

Shareholder yield

-2.24%

Metric	Value
10Y price change	-7.25%
10Y return CAGR	-0.39%
10Y total return	-3.86%
150-day SMA	$35.17
15Y price change	-4.78%
15Y return CAGR	0.64%
15Y total return	10.08%
1D price change	-1.23%
1M price change	2.12%
1M total return	2.12%
1W price change	-2.03%
1W total return	-2.03%
1Y price change	104.08%
1Y return CAGR	104.18%
1Y total return	104.08%
20-day SMA	$40.28
200-day SMA	$34.49
20Y price change	20.36%
20Y return CAGR	1.95%
20Y total return	46.99%
3M price change	28.76%
3M total return	28.76%
3Y price change	392.86%
3Y return CAGR	70.16%
3Y total return	392.86%
50-day SMA	$38.90
50-day SMA vs 200-day SMA	50over200
52-week high	$42.02
52-week high date	2026-10-09
52-week low	$19.23
52-week low date	2025-10-28
5Y price change	348.15%
5Y return CAGR	34.99%
5Y total return	348.15%
6M price change	28.02%
6M total return	28.02%
All-time high	$72.31
All-time high date	2015-07-28
All-time low	$0.30
All-time low date	1988-02-03
Average true range (ATR)	$1.11
Average volume	6M
Beta (1Y)	0.04
Beta (2Y)	-0.56
Beta (5Y)	0.82
Change from 52-week high	-5.06%
Change from 52-week low	107.46%
Change from all-time high	-44.65%
Change from all-time low	13,379.29%
Change from open	0.36%
Day's gap	-1.58%
Dollar volume	$133.8M
High price	$40.49
Low price	$39.50
Monthly RSI	76.18
Open price	$39.75
Position in 52-week range	39.9%
Premarket change	-1.66%
Premarket close	$40.39
Premarket price	$39.72
Premarket volume	65.7K
Previous close	$40.39
Price vs 150-day SMA	13.78%
Price vs 20-day SMA	-0.65%
Price vs 200-day SMA	16.04%
Price vs 50-day SMA	2.88%
Relative volume	0.56
RSI	51.33
Sharpe ratio	1.92
Sharpe ratio (3Y)	1.4
Sharpe ratio (5Y)	0.76
Sortino ratio	4.17
Sortino ratio (3Y)	2.68
Sortino ratio (5Y)	1.43
Volume	3.4M
Weekly RSI	64.04
YTD price change	28.23%
YTD total return	28.23%

Metric

Value

10Y price change

-7.25%

10Y return CAGR

-0.39%

10Y total return

-3.86%

150-day SMA

$35.17

15Y price change

-4.78%

15Y return CAGR

0.64%

15Y total return

10.08%

1D price change

-1.23%

1M price change

2.12%

1M total return

2.12%

1W price change

-2.03%

1W total return

-2.03%

1Y price change

104.08%

1Y return CAGR

104.18%

1Y total return

104.08%

20-day SMA

$40.28

200-day SMA

$34.49

20Y price change

20.36%

20Y return CAGR

1.95%

20Y total return

46.99%

3M price change

28.76%

3M total return

28.76%

3Y price change

392.86%

3Y return CAGR

70.16%

3Y total return

392.86%

50-day SMA

$38.90

50-day SMA vs 200-day SMA

50over200

52-week high

$42.02

52-week high date

2026-10-09

52-week low

$19.23

52-week low date

2025-10-28

5Y price change

348.15%

5Y return CAGR

34.99%

5Y total return

348.15%

6M price change

28.02%

6M total return

28.02%

All-time high

$72.31

All-time high date

2015-07-28

All-time low

$0.30

All-time low date

1988-02-03

Average true range (ATR)

$1.11

Average volume

Beta (1Y)

0.04

Beta (2Y)

-0.56

Beta (5Y)

0.82

Change from 52-week high

-5.06%

Change from 52-week low

107.46%

Change from all-time high

-44.65%

Change from all-time low

13,379.29%

Change from open

0.36%

Day's gap

-1.58%

Dollar volume

$133.8M

High price

$40.49

Low price

$39.50

Monthly RSI

76.18

Open price

$39.75

Position in 52-week range

39.9%

Premarket change

-1.66%

Premarket close

$40.39

Premarket price

$39.72

Premarket volume

65.7K

Previous close

$40.39

Price vs 150-day SMA

13.78%

Price vs 20-day SMA

-0.65%

Price vs 200-day SMA

16.04%

Price vs 50-day SMA

2.88%

Relative volume

0.56

RSI

51.33

Sharpe ratio

1.92

Sharpe ratio (3Y)

1.4

Sharpe ratio (5Y)

0.76

Sortino ratio

4.17

Sortino ratio (3Y)

2.68

Sortino ratio (5Y)

1.43

Volume

3.4M

Weekly RSI

64.04

YTD price change

28.23%

YTD total return

28.23%

Metric	Value
Float	1.1B
Float percentage	93.43%
Shares change (QoQ)	-1.19%
Shares change (YoY)	2.24%
Shares held by insiders	0.43%
Shares held by institutions	74.35%
Shares outstanding	1.2B
Short % of shares	2.57%
Short ratio	9.1 days

Metric

Value

Float

1.1B

Float percentage

93.43%

Shares change (QoQ)

-1.19%

Shares change (YoY)

2.24%

Shares held by insiders

0.43%

Shares held by institutions

74.35%

Shares outstanding

1.2B

Short % of shares

2.57%

Short ratio

9.1 days

Teva Pharmaceutical Industries Limited (TEVA)

Price

Financial snapshot

Fair-value bridge

Latest news · TEVA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TEVA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TEVA

Frequently asked questions